Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerance of Experimental Low pH Mouthwash
NCT06010758Phase 4Completed
- Sponsor
- Johnson & Johnson
- Start
- Jul 2023
- Primary completion
- Aug 2023
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 4 trial of Cetylpyridinium chloride mouthwash in dental caries, sponsored by Johnson & Johnson. Started Jul 2023; status: completed.
02
Drugs
Cetylpyridinium chloride mouthwash
03
Conditions
dental caries
Beyond the preview
Go deeper on NCT06010758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06010758.